Miralax and Obstruction of the ureteropelvic junction - from FDA reports


There is no Obstruction of the ureteropelvic junction reported by people who take Miralax yet. This review analyzes which people have Obstruction of the ureteropelvic junction with Miralax. It is created by eHealthMe based on reports from FDA, and is updated regularly.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our independent and original studies have been referenced on 400+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO.



On Aug, 22, 2018

No report is found.

Are you new to Miralax or have questions?

Volunteer or get paid to help people with your care experience



Related studies

Miralax

Miralax has active ingredients of polyethylene glycol 3350. It is often used in constipation. (latest outcomes from Miralax 35,967 users)

Obstruction Of The Ureteropelvic Junction

Obstruction of the ureteropelvic junction (a blockage in the area that connects the renal pelvis (part of the kidney) to one of the tubes (ureters) that move urine) has been reported by people with rheumatoid arthritis (latest reports from 2 Obstruction of the ureteropelvic junction patients).


Drugs that are associated with Obstruction of the ureteropelvic junction
Obstruction of the ureteropelvic junction
Could your condition cause Obstruction of the ureteropelvic junction
Obstruction of the ureteropelvic junction
Miralax side effects
Browse all side effects of Miralax
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Miralax and have Obstruction of the ureteropelvic junction


You are not alone. Join our personalized support groups:


Recent updates

General studies

You could also:

  • Print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.